-+ 0.00%
-+ 0.00%
-+ 0.00%

Global Stocks Estimated To Be Trading Below Intrinsic Values In December 2025

Simply Wall St·12/24/2025 09:07:49
语音播报

As we approach the end of 2025, global markets are navigating a complex landscape marked by mixed economic signals and shifting monetary policies. With interest rate adjustments in major economies like Japan and Europe, alongside fluctuating inflation rates in the U.S., investors are keenly observing these developments for potential opportunities. In such an environment, identifying stocks trading below their intrinsic values can be particularly appealing to investors seeking value amid market volatility and economic uncertainty.

Top 10 Undervalued Stocks Based On Cash Flows

Name Current Price Fair Value (Est) Discount (Est)
Sanoma Oyj (HLSE:SANOMA) €9.21 €18.40 49.9%
Redelfi (BIT:RDF) €11.70 €23.30 49.8%
NEXON Games (KOSDAQ:A225570) ₩12270.00 ₩24519.40 50%
Mobvista (SEHK:1860) HK$15.40 HK$30.69 49.8%
LINK Mobility Group Holding (OB:LINK) NOK32.95 NOK65.74 49.9%
Exail Technologies (ENXTPA:EXA) €84.10 €167.48 49.8%
cyan (XTRA:CYR) €2.26 €4.50 49.8%
Cowell e Holdings (SEHK:1415) HK$27.92 HK$55.44 49.6%
Artifex Mundi (WSE:ART) PLN12.20 PLN24.36 49.9%
Andes Technology (TWSE:6533) NT$242.50 NT$481.61 49.6%

Click here to see the full list of 490 stocks from our Undervalued Global Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Almoosa Health (SASE:4018)

Overview: Almoosa Health Company operates as a private healthcare provider in the Kingdom of Saudi Arabia with a market cap of SAR7.93 billion.

Operations: The company's revenue is derived from three main segments: Rehabilitation (SAR162.41 million), Pharmaceuticals (SAR295.83 million), and Medical Services (SAR902.20 million).

Estimated Discount To Fair Value: 41.2%

Almoosa Health is trading at SAR179, significantly below its estimated fair value of SAR304.19, indicating potential undervaluation based on cash flows. Recent earnings growth and revenue increases bolster this view, with net income rising to SAR154.5 million for the first nine months of 2025. However, despite strong earnings forecasts and a new credit facility for hospital expansion, investors should note the forecasted low return on equity in three years (13.4%).

SASE:4018 Discounted Cash Flow as at Dec 2025
SASE:4018 Discounted Cash Flow as at Dec 2025

Xizang Gaozheng Civil Explosives (SZSE:002827)

Overview: Xizang Gaozheng Civil Explosives Co., Ltd. operates in the civil explosives industry and has a market cap of CN¥10.65 billion.

Operations: Xizang Gaozheng Civil Explosives Co., Ltd. generates its revenue primarily from the civil explosives sector.

Estimated Discount To Fair Value: 46.3%

Xizang Gaozheng Civil Explosives is trading at CN¥41.68, substantially below its estimated fair value of CN¥77.66, highlighting potential undervaluation based on cash flows. The company reported sales of CNY 1.26 billion for the first nine months of 2025, with net income rising to CNY 126.05 million. Analysts forecast significant earnings growth over the next three years and a high return on equity (25.8%), although recent bylaw changes may affect future operations.

SZSE:002827 Discounted Cash Flow as at Dec 2025
SZSE:002827 Discounted Cash Flow as at Dec 2025

Food & Life Companies (TSE:3563)

Overview: Food & Life Companies Ltd. operates a chain of sushi restaurants and has a market cap of ¥870.59 billion.

Operations: The company's revenue segments include the Japan Sushiro Business at ¥265.90 billion, Overseas Sushiro Business at ¥131.42 billion, Kyotaru Business at ¥23.53 billion, and Japan Sugidama Business at ¥8.28 billion.

Estimated Discount To Fair Value: 24.3%

Food & Life Companies is trading at ¥7,758, significantly below its estimated fair value of ¥10,246.58, suggesting undervaluation based on cash flows. Despite recent share price volatility, earnings grew by 56.7% over the past year and are forecast to grow at 12.24% annually, outpacing the JP market's 8.5%. The company projects a profit attributable to owners of ¥24 billion for fiscal 2026 and maintains a consistent dividend payout of ¥35 per share.

TSE:3563 Discounted Cash Flow as at Dec 2025
TSE:3563 Discounted Cash Flow as at Dec 2025

Where To Now?

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.